Abstract
Gold nanoparticle (GNP) based contrast agents that are highly specific and sensitive for both optical and X-ray/CT imaging modalities are being developed for detecting the cancer expressing nucleolin and matrix metallo-proteinase 14 (MMP-14) on the cell membrane: Nucleolin is normally present in the nucleus. For many cancer cells, however, it is over-expressed on the cell membrane, having it to be a good cancer marker. Aptamer AS1411 is known to be an excellent target for nucleolin and also known to treat several cancer types; and MMP-14 in cancer is involved in tumor angiogenesis, blood vessel re-organization, and metastasis. In the proposed agent, AS1411 is selected as the cancer targeting molecule; and the unique property of GNPs of modulating fluorescence are utilized to allow the agent to trigger its fluorescence upon reacting with MMP-14, at an enhanced fluorescence level. GNPs are also natural X-ray/CT contrast agent. Here, as a part of on-going development of the dual-modality contrast agent, we report that conjugating a safe, NIR fluorophore Cypate at a precisely determined distance from the GNP enhanced the Cypate fluorescence up to two times. In addition, successful conjugation of the nucleolin target AS1411 onto the GNP was confirmed and among the GNPs size range 5–30 nm tested, 10 nm GNPs showed the highest X-ray/CT enhancement.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
National Cancer Institute of the U.S. National Insitute of Health (2015) Cancer nanotechnology plan 2015, https://nano.cancer.gov/objects/pdfs/caNanoPlan%202015%20-%20Front%20Matter%20(WEB_508).pdf
Cassidy PJ, Radda GK (2005) Molecular imaging perspectives. J R Soc Interface 2:133–144
Malik MT, O’Toole MG, Casson LK, Thomas SD, Bardi GT, Reyes-Reyes EM, Ng CK, Kang KA, Bates PJ (2015) AS1411-conjugated gold nanospheres and their potential for breast cancer therapy. Oncotarget 6(26):22270–22281
Curran S, Murray GI (1999) Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 189:300–308
Kang KA, Wang JT, Jasinski JB et al (2011) Fluorescence manipulation by gold nanoparticles: from complete quenching to extensive enhancement. J Nanobiotechnol 9:16. doi:10.1186/1477-3155-9-16
Wang JT, Achilefu S, Nantz M, Kang KA (2011) Gold nanoparticle-fluorophore complex for conditionally fluorescing signal mediator. Anal Chim Acta 695:96–104
Wang JT, Moore J, Laulhe S, Nantz M, Achilefu S, Kang KA (2012) Fluorophore-gold nanoparticle complex for sensitive optical biosensing and imaging. Nanotechnology 23:095501. doi:10.1088/0957-4484/23/9/095501
Kang KA, Wang JT (2014a) Conditionally activating optical contrast agent with enhanced sensitivity via gold nanoparticle plasmon energy transfer: feasibility study. J Nanobiotechnol 12:56. doi:10.1186/s12951-014-0056-2
Kang KA, Wang JT (2014b) Smart dual-mode fluorescent gold nanoparticle agents. WIREs Nanomed Nanobiotechnol 6:398–409
Nguyen MD, Kang KA (2016) MMP-14 triggered fluorescence contrast agent. Adv Exp Med Biol 923:413–419
Chien C-C, Chen H-H, Lai S-F et al (2012) Gold nanoparticles as high-resolution X-ray imaging contrast agents for the analysis of tumor-related microvasculature. J Nanobiotechnol 10:10. doi:10.1186/1477-3155-10-10
Achilefu S, Dorshow RB, Bugaj JE, Rajagopalan R (2000) Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. Investig Radiol 35:479–485
Duchesne L, Gentili D, Comes-Franchini M et al (2008) Robust ligand shells for biological applications of gold nanoparticles. Langmuir 24(23):13572–13580
Hurst SJ, Lytton-Jean AKR, Mirkin CA (2006) Maximizing DNA loading on a range of gold nanoparticle sizes. Anal Chem 78:8313–8318
Acknowledgments
The authors acknowledge the financial supported with the NIH Grant 1R15CA173693. The authors also thank Dr. Rosendo Estrada for his advice on various chemical reactions involved in the development of this optical contrast agent.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Kang, K.A., Nguyen, MD. (2017). Gold Nanoparticle-Based Fluorescent Contrast Agent with Enhanced Sensitivity. In: Halpern, H., LaManna, J., Harrison, D., Epel, B. (eds) Oxygen Transport to Tissue XXXIX. Advances in Experimental Medicine and Biology, vol 977. Springer, Cham. https://doi.org/10.1007/978-3-319-55231-6_52
Download citation
DOI: https://doi.org/10.1007/978-3-319-55231-6_52
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-55229-3
Online ISBN: 978-3-319-55231-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)